| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Coastlands Capital LP | 5% | -16% | $6,733,682 | -$1,410,519 | 3,937,826 | -17% | Coastlands Capital LP | 31 Dec 2025 |
| BlackRock, Inc. | 4.6% | -16% | $5,474,994 | +$563,100 | 3,625,824 | +11% | BlackRock, Inc. | 31 Dec 2025 |
| VANGUARD GROUP INC | 5.5% | $8,992,818 | 3,318,383 | The Vanguard Group | 30 Jun 2025 | |||
| ARMISTICE CAPITAL, LLC | 5% | $10,259,798 | 3,137,553 | Armistice Capital, LLC | 31 Dec 2024 | |||
| Frazier Life Sciences Public Fund, L.P. | 2% | $3,847,923 | 1,176,735 | James N. Topper | 31 Dec 2024 |
As of 31 Dec 2025, 89 institutional investors reported holding 43,989,694 shares of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN). This represents 56% of the company’s total 78,914,349 outstanding shares.
The largest institutional shareholders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BVF INC/IL | 8% | 6,293,282 | 0% | 0.32% | $9,502,856 |
| VANGUARD GROUP INC | 5.1% | 4,039,686 | +24% | 0% | $6,099,926 |
| BlackRock, Inc. | 4.6% | 3,627,208 | +4.7% | 0% | $5,477,084 |
| Defilade Capital Management, L.P. | 4.2% | 3,290,450 | 0% | 0.67% | $4,968,580 |
| Ensign Peak Advisors, Inc | 3.1% | 2,464,919 | +95% | 0.01% | $3,722,028 |
| Zimmer Partners, LP | 3% | 2,384,228 | +31% | 0.09% | $3,600,184 |
| SPHERA FUNDS MANAGEMENT LTD. | 2.7% | 2,132,131 | +67% | 0.67% | $3,219,518 |
| Blue Owl Capital Holdings LP | 2.4% | 1,929,912 | +97% | 0.22% | $2,914,167 |
| ADAR1 Capital Management, LLC | 2.3% | 1,821,812 | 0.21% | $2,750,936 | |
| Jefferies Financial Group Inc. | 2% | 1,580,625 | 0.02% | $2,386,744 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,421,617 | +3.8% | 0% | $2,146,964 |
| Catalio Capital Management, LP | 1.6% | 1,259,820 | +19% | 0.36% | $1,902,328 |
| AWM Investment Company, Inc. | 1.4% | 1,100,000 | 0.16% | $1,661,000 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.3% | 1,039,275 | 0.24% | $1,569,305 | |
| Stonepine Capital Management, LLC | 1.1% | 893,100 | 1.1% | $1,348,581 | |
| Sanofi | 1% | 814,980 | 0% | 0.4% | $1,230,620 |
| STATE STREET CORP | 0.98% | 773,885 | +18% | 0% | $1,168,566 |
| CM Management, LLC | 0.82% | 650,000 | +8.3% | 0.83% | $981,500 |
| 22NW, LP | 0.81% | 636,364 | 0% | 0.74% | $960,910 |
| SG Americas Securities, LLC | 0.8% | 627,392 | 0% | $947,000 | |
| UBS Group AG | 0.75% | 593,131 | +535% | 0% | $895,628 |
| Caligan Partners LP | 0.7% | 555,978 | 0.08% | $839,527 | |
| JANE STREET GROUP, LLC | 0.62% | 489,376 | +151% | 0% | $738,958 |
| NORTHERN TRUST CORP | 0.54% | 429,813 | +0.29% | 0% | $649,018 |
| Focus Partners Wealth | 0.4% | 317,443 | 0% | $479,339 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 43,989,694 | $66,415,664 | -$2,708,395 | $1.51 | 89 |
| 2025 Q3 | 36,469,559 | $94,453,818 | -$12,219,070 | $2.59 | 82 |
| 2025 Q2 | 40,843,175 | $110,685,079 | +$5,557,133 | $2.71 | 85 |
| 2025 Q1 | 38,448,901 | $130,340,726 | -$2,283,033 | $3.39 | 83 |
| 2024 Q4 | 38,479,556 | $158,542,263 | +$81,995,653 | $4.12 | 75 |
| 2024 Q3 | 18,485,827 | $46,028,922 | +$410,879 | $2.49 | 33 |
| 2024 Q2 | 18,259,810 | $48,206,187 | +$22,892,459 | $2.64 | 31 |
| 2024 Q1 | 9,595,061 | $19,765,324 | +$914,973 | $2.06 | 28 |
| 2023 Q4 | 9,153,168 | $16,475,058 | +$507,102 | $1.80 | 28 |
| 2023 Q3 | 8,917,722 | $12,217,005 | -$186,914 | $1.37 | 28 |
| 2023 Q2 | 9,275,200 | $12,707,758 | +$2,932,975 | $1.37 | 32 |
| 2023 Q1 | 6,240,661 | $14,727,632 | -$15,081 | $2.36 | 29 |
| 2022 Q4 | 6,249,494 | $14,377,182 | -$299,603 | $2.28 | 27 |
| 2022 Q3 | 6,267,437 | $17,296,971 | -$726,076 | $2.76 | 26 |
| 2022 Q2 | 6,534,650 | $15,944,119 | -$1,242,145 | $2.44 | 27 |
| 2022 Q1 | 7,004,967 | $27,598,192 | -$4,350,190 | $3.94 | 30 |
| 2021 Q4 | 7,884,710 | $34,745,775 | -$3,532,209 | $4.41 | 34 |
| 2021 Q3 | 8,434,281 | $52,121,569 | -$6,530,652 | $6.18 | 29 |
| 2021 Q2 | 9,423,304 | $74,527,000 | +$5,445,356 | $7.91 | 29 |
| 2021 Q1 | 8,317,680 | $88,956,000 | +$88,566,000 | $10.70 | 32 |
| 2020 Q4 | 36,111 | $556,000 | +$556,000 | $15.40 | 1 |